[The when and how of therapy for hyperlipoproteinemia].
Hyperlipoproteinemia is found in about 10--15% of the adult population. There is a strong correlation between elevated total and LDL cholesterol levels, decreased HDL cholesterol values and the incidence of coronary heart disease. Large-scale screening for this strong risk factor should be initiated at an early stage, when possible even in childhood. Dietary treatment is the basis of all lipid-lowering therapy. Lipid-lowering drugs should be given only in addition to a carefully controlled diet. Dietary and drug treatment of hyperlipoproteinemia is discussed.
D001161:Arteriosclerosis / Q000378:metabolism; D002784:Cholesterol / Q000097:blood; D002994:Clofibrate / Q000627:therapeutic use; D004338:Drug Combinations; D006801:Humans; D006949:Hyperlipidemias / Q000178:diet therapy* / Q000188:drug therapy; D008075:Lipoproteins, HDL / Q000097:blood; D008077:Lipoproteins, LDL / Q000097:blood; D009539:Nicotinic Acids / Q000627:therapeutic use; D014280:Triglycerides / Q000097:blood
D004338:Drug Combinations; D008075:Lipoproteins, HDL; D008077:Lipoproteins, LDL; D009539:Nicotinic Acids; D014280:Triglycerides; D002784:Cholesterol; D002994:Clofibrate
Therapie der Hyperlipoproteinämien--wann? wie?